These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38890737)

  • 21. Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway.
    Zhang Y; Zhang Y; Wang J; Gu H
    Biomed Res Int; 2020; 2020():5391058. PubMed ID: 33145353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-situ-formed immunotherapeutic and hemostatic dual drug-loaded nanohydrogel for preventing postoperative recurrence of hepatocellular carcinoma.
    Ke J; Liu Y; Liu F; Cai H; Li X; Zhang Z; Wang N; Shao B; Wang Z; Han M; Ji B
    J Control Release; 2024 Aug; 372():141-154. PubMed ID: 38885842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting autophagy enhances heat stress-induced apoptosis via the ATP-AMPK-mTOR axis for hepatocellular carcinoma.
    Jiang J; Chen S; Li K; Zhang C; Tan Y; Deng Q; Chai Y; Wang X; Chen G; Feng K; Zhang L; Xie CM; Ma K
    Int J Hyperthermia; 2019; 36(1):499-510. PubMed ID: 31007109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response.
    Qi X; Yang M; Ma L; Sauer M; Avella D; Kaifi JT; Bryan J; Cheng K; Staveley-O'Carroll KF; Kimchi ET; Li G
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMGB1 released from dead tumor cells after insufficient radiofrequency ablation promotes progression of HCC residual tumor via ERK1/2 pathway.
    Zhou Y; Liu X; Zhang W; Xu Y; Zhang Q; Xiong S; Tang H; Luo B
    Int J Hyperthermia; 2023; 40(1):2174709. PubMed ID: 36755436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.
    Su T; Liao J; Dai Z; Xu L; Chen S; Wang Y; Peng Z; Zhang Q; Peng S; Kuang M
    Oncogene; 2018 Jun; 37(26):3514-3527. PubMed ID: 29559743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irreversible electroporation induces CD8
    Dai Z; Wang Z; Lei K; Liao J; Peng Z; Lin M; Liang P; Yu J; Peng S; Chen S; Kuang M
    Cancer Lett; 2021 Apr; 503():1-10. PubMed ID: 33444692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
    Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
    J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A well-matched marriage of immunotherapy and radiofrequency ablation to reduce the relapse and progression of hepatocellular carcinoma.
    Liao R; Song P; Duan Y; Ye W; Yin K; Kang M; Yu Y; Yang J; Tang W
    Biosci Trends; 2022 Nov; 16(5):377-380. PubMed ID: 36089338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiofrequency ablation triggers the migration of hepatocellular carcinoma cells by suppressing miR-148a-5p.
    Wang H; Cao Y; Hu K; Li Q; Yang Y; Wang L; Qin X; Qiao B; Cheng L; Li P; Dui W
    Biol Chem; 2020 Jul; 401(8):985-994. PubMed ID: 32142478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iodine-125 Brachytherapy Can Prolong Progression-Free Survival of Patients with Locoregional Recurrence and/or Residual Hepatocellular Carcinoma After Radiofrequency Ablation.
    Chen L; Ying X; Zhang D; Lai L; Wu F; Tu J; Ji J
    Cancer Biother Radiopharm; 2021 Dec; 36(10):820-826. PubMed ID: 32551979
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
    Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
    Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting N
    Zhu S; Wu Y; Zhang X; Peng S; Xiao H; Chen S; Xu L; Su T; Kuang M
    Mol Ther; 2023 Jun; 31(6):1596-1614. PubMed ID: 35965412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin enhances the efficacy of anti-PD-L1 by improving hypoxia in residual tumors after insufficient radiofrequency ablation.
    Ren Y; Zhu L; Guo Y; Ma J; Yang L; Zheng C; Dong X
    J Pharm Anal; 2024 Aug; 14(8):100942. PubMed ID: 39263355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
    Tanaka T; Takata K; Kunimoto H; Fukuda H; Yamauchi R; Tsuchiya N; Inomata S; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
    Oncology; 2020; 98(12):859-868. PubMed ID: 32799203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTLA-4 Blockade Suppresses Progression of Residual Tumors and Improves Survival After Insufficient Radiofrequency Ablation in a Subcutaneous Murine Hepatoma Model.
    Zhang L; Wang J; Jiang J; Zhang M; Shen J
    Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1353-1361. PubMed ID: 32607616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling.
    Zhang N; Wang L; Chai ZT; Zhu ZM; Zhu XD; Ma DN; Zhang QB; Zhao YM; Wang M; Ao JY; Ren ZG; Gao DM; Sun HC; Tang ZY
    PLoS One; 2014; 9(12):e115949. PubMed ID: 25542041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localized RNA interference therapy to eliminate residual lung cancer after incomplete microwave ablation.
    Cao F; Wan C; Xie L; Qi H; Shen L; Chen S; Song Z; Fan W
    Thorac Cancer; 2019 Jun; 10(6):1369-1377. PubMed ID: 31017731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.